首页> 外文期刊>Modern Pathology >Expression profiling of 519 kinase genes in matched malignant peripheral nerve sheath tumor|[sol]|plexiform neurofibroma samples is discriminatory and identifies mitotic regulators BUB1B, PBK and NEK2 as overexpressed with transformation
【24h】

Expression profiling of 519 kinase genes in matched malignant peripheral nerve sheath tumor|[sol]|plexiform neurofibroma samples is discriminatory and identifies mitotic regulators BUB1B, PBK and NEK2 as overexpressed with transformation

机译:匹配的恶性周围神经鞘瘤| [丛]状神经纤维瘤样品中519个激酶基因的表达谱具有歧视性,并鉴定有丝分裂调节剂BUB1B,PBK和NEK2过度表达

获取原文
           

摘要

About 50% of all malignant peripheral nerve sheath tumors (MPNSTs) arise as neurofibromatosis type 1 associated lesions. In those patients malignant peripheral nerve sheath tumors are thought to arise through malignant transformation of a preexisting plexiform neurofibroma. The molecular changes associated with this transformation are still poorly understood. We sought to test the hypothesis that dysregulation of expression of kinases contributes to this malignant transformation. We analyzed expression of all 519 kinase genes in the human genome using the nanostring nCounter system. Twelve cases of malignant peripheral nerve sheath tumor arising in a background of preexisting plexiform neurofibroma were included. Both components were separately sampled. Statistical analysis compared global changes in expression levels as well as changes observed in the pairwise comparison of samples taken from the same surgical specimen. Immunohistochemical studies were performed on tissue array slides to confirm expression of selected proteins. The expression pattern of kinase genes can separate malignant peripheral nerve sheath tumors and preexisting plexiform neurofibromas. The majority of kinase genes is downregulated rather than overexpressed with malignant transformation. The patterns of expression changes are complex without simple recurring alteration. Pathway analysis demonstrates that differentially expressed kinases are enriched for kinases involved in the direct regulation of mitosis, and several of these show increased expression in malignant peripheral nerve sheath tumors. Immunohistochemical studies for the mitotic regulators BUB1B, PBK and NEK2 confirm higher expression levels at the protein level. These results suggest that the malignant transformation of plexiform neurofibroma is associated with distinct changes in the expression of kinase genes. The patterns of these changes are complex and heterogeneous. There is no single unifying alteration. Kinases involved in mitotic regulation are particularly enriched in the pool of differentially expressed kinases. Some of these are overexpressed and are therefore possible targets for kinase inhibitors.
机译:所有恶性周围神经鞘瘤(MPNSTs)约50%发生为1型神经纤维瘤病相关病变。在那些患者中,恶性周围神经鞘瘤被认为是由于先前存在的丛状神经纤维瘤的恶性转化而引起的。与这种转化有关的分子变化仍然知之甚少。我们试图检验一种假设,即激酶表达失调会导致这种恶性转化。我们使用nanostring nCounter系统分析了人类基因组中所有519个激酶基因的表达。包括在先前存在的丛状神经纤维瘤的背景下发生的十二例恶性周围神经鞘瘤。两种组分都分别取样。统计分析比较了表达水平的整体变化以及从同一手术标本中获得的样品的成对比较中观察到的变化。在组织阵列载玻片上进行了免疫组织化学研究,以确认所选蛋白质的表达。激酶基因的表达模式可以分离恶性周围神经鞘瘤和先前存在的丛状神经纤维瘤。大多数激酶基因被下调而不是被恶性转化过度表达。表达更改的模式很复杂,没有简单的重复更改。途径分析表明,差异表达的激酶富含直接参与有丝分裂调控的激酶,其中一些在恶性周围神经鞘瘤中表达增加。对有丝分裂调节剂BUB1B,PBK和NEK2的免疫组织化学研究证实,在蛋白质水平上有较高的表达水平。这些结果表明,丛状神经纤维瘤的恶性转化与激酶基因表达的明显变化有关。这些变化的模式是复杂且异质的。没有单一的统一变更。参与有丝分裂调控的激酶在差异表达激酶库中特别丰富。其中一些过表达,因此可能是激酶抑制剂的靶标。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号